165 related articles for article (PubMed ID: 33852963)
21. Genetic prognostication in uveal melanoma.
Dogrusöz M; Jager MJ
Acta Ophthalmol; 2018 Jun; 96(4):331-347. PubMed ID: 29105334
[TBL] [Abstract][Full Text] [Related]
22. BAP1 Loss Is Associated with DNA Methylomic Repatterning in Highly Aggressive Class 2 Uveal Melanomas.
Field MG; Kuznetsov JN; Bussies PL; Cai LZ; Alawa KA; Decatur CL; Kurtenbach S; Harbour JW
Clin Cancer Res; 2019 Sep; 25(18):5663-5673. PubMed ID: 31285370
[TBL] [Abstract][Full Text] [Related]
23. A metastasis modifier locus on human chromosome 8p in uveal melanoma identified by integrative genomic analysis.
Onken MD; Worley LA; Harbour JW
Clin Cancer Res; 2008 Jun; 14(12):3737-45. PubMed ID: 18559591
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma.
Patrone S; Maric I; Rutigliani M; Lanza F; Puntoni M; Banelli B; Rancati S; Angelini G; Amaro A; Ligorio P; Defferrari C; Castagnetta M; Bandelloni R; Mosci C; DeCensi A; Romani M; Pfeffer U; Viaggi S; Coviello DA
Genes Chromosomes Cancer; 2018 Aug; 57(8):387-400. PubMed ID: 29689622
[TBL] [Abstract][Full Text] [Related]
25. Identification of survival-related genes and a novel gene-based prognostic signature involving the tumor microenvironment of uveal melanoma.
Lei S; Zhang Y
Int Immunopharmacol; 2021 Jul; 96():107816. PubMed ID: 34162166
[TBL] [Abstract][Full Text] [Related]
26. Single-cell analysis reveals new evolutionary complexity in uveal melanoma.
Durante MA; Rodriguez DA; Kurtenbach S; Kuznetsov JN; Sanchez MI; Decatur CL; Snyder H; Feun LG; Livingstone AS; Harbour JW
Nat Commun; 2020 Jan; 11(1):496. PubMed ID: 31980621
[TBL] [Abstract][Full Text] [Related]
27. Identification of prognostic genes in uveal melanoma microenvironment.
Luo H; Ma C
PLoS One; 2020; 15(11):e0242263. PubMed ID: 33196683
[TBL] [Abstract][Full Text] [Related]
28. Genetic heterogeneity in uveal melanoma assessed by multiplex ligation-dependent probe amplification.
Dopierala J; Damato BE; Lake SL; Taktak AF; Coupland SE
Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):4898-905. PubMed ID: 20484589
[TBL] [Abstract][Full Text] [Related]
29. Genotype-dependent sensitivity of uveal melanoma cell lines to inhibition of B-Raf, MEK, and Akt kinases: rationale for personalized therapy.
Mitsiades N; Chew SA; He B; Riechardt AI; Karadedou T; Kotoula V; Poulaki V
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7248-55. PubMed ID: 21828154
[TBL] [Abstract][Full Text] [Related]
30. Focus on cutaneous and uveal melanoma specificities.
Pandiani C; Béranger GE; Leclerc J; Ballotti R; Bertolotto C
Genes Dev; 2017 Apr; 31(8):724-743. PubMed ID: 28512236
[TBL] [Abstract][Full Text] [Related]
31. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
[TBL] [Abstract][Full Text] [Related]
32. Association of Partial Chromosome 3 Deletion in Uveal Melanomas With Metastasis-Free Survival.
Rodrigues M; Ait Rais K; Salviat F; Algret N; Simaga F; Barnhill R; Gardrat S; Servois V; Mariani P; Piperno-Neumann S; Roman-Roman S; Delattre O; Cassoux N; Savignoni A; Stern MH; Pierron G
JAMA Ophthalmol; 2020 Feb; 138(2):182-188. PubMed ID: 31895446
[TBL] [Abstract][Full Text] [Related]
33. Development of new therapeutic options for the treatment of uveal melanoma.
Wang JZ; Lin V; Toumi E; Wang K; Zhu H; Conway RM; Madigan MC; Murray M; Cherepanoff S; Zhou F; Shu W
FEBS J; 2021 Nov; 288(21):6226-6249. PubMed ID: 33838075
[TBL] [Abstract][Full Text] [Related]
34. Mitochondrial DNA polymorphisms and biogenesis genes in primary and metastatic uveal melanoma cell lines.
Singh L; Atilano SR; Jager MJ; Kenney MC
Cancer Genet; 2021 Aug; 256-257():91-99. PubMed ID: 34082186
[TBL] [Abstract][Full Text] [Related]
35. Single cell analysis to dissect molecular heterogeneity and disease evolution in metastatic melanoma.
Fattore L; Ruggiero CF; Liguoro D; Mancini R; Ciliberto G
Cell Death Dis; 2019 Oct; 10(11):827. PubMed ID: 31672982
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA expression analysis and Multiplex ligation-dependent probe amplification in metastatic and non-metastatic uveal melanoma.
Larsen AC; Holst L; Kaczkowski B; Andersen MT; Manfé V; Siersma VD; Kolko M; Kiilgaard JF; Winther O; Prause JU; Gniadecki R; Heegaard S
Acta Ophthalmol; 2014 Sep; 92(6):541-9. PubMed ID: 24373459
[TBL] [Abstract][Full Text] [Related]
37. EPIGENETIC CHANGES IN MALIGNANT UVEAL MELANOMA AND POSSIBILITIES OF THEIR THERAPEUTIC TARGETING.
Smolková B; Demková L
Cesk Slov Oftalmol; 2020; 76(2):55-60. PubMed ID: 33126799
[TBL] [Abstract][Full Text] [Related]
38. Oncogenic mutations in GNAQ occur early in uveal melanoma.
Onken MD; Worley LA; Long MD; Duan S; Council ML; Bowcock AM; Harbour JW
Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5230-4. PubMed ID: 18719078
[TBL] [Abstract][Full Text] [Related]
39. Novel mouse model for primary uveal melanoma: a pilot study.
Süsskind D; Hurst J; Rohrbach JM; Schnichels S
Clin Exp Ophthalmol; 2017 Mar; 45(2):192-200. PubMed ID: 27505446
[TBL] [Abstract][Full Text] [Related]
40. The Role of Immune Checkpoint Blockade in Uveal Melanoma.
Wessely A; Steeb T; Erdmann M; Heinzerling L; Vera J; Schlaak M; Berking C; Heppt MV
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
